Skip to main content
Top
Published in: AIDS and Behavior 2/2015

01-02-2015 | Original Paper

The Efficacy of Serostatus Disclosure for HIV Transmission Risk Reduction

Authors: Ann A. O’Connell, Sandra J. Reed, Julianne A. Serovich

Published in: AIDS and Behavior | Issue 2/2015

Login to get access

Abstract

Interventions to assist HIV+ persons in disclosing their serostatus to sexual partners can play an important role in curbing rates of HIV transmission among men who have sex with men (MSM). Based on the methods of Pinkerton and Galletly (AIDS Behav 11:698–705, 2007), we develop a mathematical probability model for evaluating effectiveness of serostatus disclosure in reducing the risk of HIV transmission and extend the model to examine the impact of serosorting. In baseline data from 164 HIV+ MSM participating in a randomized controlled trial of a disclosure intervention, disclosure is associated with a 45.0 % reduction in the risk of HIV transmission. Accounting for serosorting, a 61.2 % reduction in risk due to disclosure was observed in serodisconcordant couples. The reduction in risk for seroconcordant couples was 38.4 %. Evidence provided supports the value of serostatus disclosure as a risk reduction strategy in HIV+ MSM. Interventions to increase serostatus disclosure and that address serosorting behaviors are needed.
Literature
4.
go back to reference Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997;44:1303–12.CrossRefPubMed Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med. 1997;44:1303–12.CrossRefPubMed
5.
go back to reference Snowden JM, Raymond HF, McFarland W. Seroadaptive behaviors among men who have sex with men in San Francisco: the situation in 2008. Sex Transm Infect. 2010;87:162–4.CrossRefPubMed Snowden JM, Raymond HF, McFarland W. Seroadaptive behaviors among men who have sex with men in San Francisco: the situation in 2008. Sex Transm Infect. 2010;87:162–4.CrossRefPubMed
6.
go back to reference Vallabhaneni S, Li X, Vittinghoff E, Donnell D, Pilcher CD, Buchbinder SP. Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men. PLoS One. 2012;7:e45718.CrossRefPubMedCentralPubMed Vallabhaneni S, Li X, Vittinghoff E, Donnell D, Pilcher CD, Buchbinder SP. Seroadaptive practices: association with HIV acquisition among HIV-negative men who have sex with men. PLoS One. 2012;7:e45718.CrossRefPubMedCentralPubMed
8.
go back to reference Pinkerton SD, Galletly CL. Reducing HIV transmission risk by increasing serostatus disclosure: a mathematical modeling analysis. AIDS Behav. 2007;11:698–705.CrossRefPubMedCentralPubMed Pinkerton SD, Galletly CL. Reducing HIV transmission risk by increasing serostatus disclosure: a mathematical modeling analysis. AIDS Behav. 2007;11:698–705.CrossRefPubMedCentralPubMed
9.
go back to reference Bird JDP, Fingerhut DD, McKirnan DJ. Ethnic differences in HIV-disclosure and sexual risk. AIDS Care. 2011;23:444–8.CrossRefPubMed Bird JDP, Fingerhut DD, McKirnan DJ. Ethnic differences in HIV-disclosure and sexual risk. AIDS Care. 2011;23:444–8.CrossRefPubMed
10.
go back to reference De Rosa CJ, Marks G. Preventive counseling of HIV-positive men and self-disclosure of serostatus to sex partners: new opportunities for prevention. Health Psychol. 1998;17(3):224–31.CrossRefPubMed De Rosa CJ, Marks G. Preventive counseling of HIV-positive men and self-disclosure of serostatus to sex partners: new opportunities for prevention. Health Psychol. 1998;17(3):224–31.CrossRefPubMed
11.
go back to reference Kalichman SC, Nachimson D. Self-efficacy and disclosure of HIV-positive serostatus to sex partners. Health Psychol. 1999;18:281–7.CrossRefPubMed Kalichman SC, Nachimson D. Self-efficacy and disclosure of HIV-positive serostatus to sex partners. Health Psychol. 1999;18:281–7.CrossRefPubMed
12.
go back to reference Marks G, Crepaz N. HIV-positive men’s sexual practices in the context of self-disclosure of HIV status. J Acquir Immune Defic Syndr. 2001;27:79–85.CrossRefPubMed Marks G, Crepaz N. HIV-positive men’s sexual practices in the context of self-disclosure of HIV status. J Acquir Immune Defic Syndr. 2001;27:79–85.CrossRefPubMed
13.
go back to reference Niccolai LM, Dorst D, Myers L, Kissinger PJ. Disclosure of HIV status to sexual partners: predictors and temporal patterns. Sex Transm Dis. 1999;26(5):281–5.CrossRefPubMed Niccolai LM, Dorst D, Myers L, Kissinger PJ. Disclosure of HIV status to sexual partners: predictors and temporal patterns. Sex Transm Dis. 1999;26(5):281–5.CrossRefPubMed
14.
go back to reference Serovich JM, Reed S, Grafsky E, Andrist D. An intervention to assist men who have sex with other men disclose their serostatus to casual sex partners: results from a pilot study. AIDS Educ Prev. 2009;21:207–19.CrossRefPubMedCentralPubMed Serovich JM, Reed S, Grafsky E, Andrist D. An intervention to assist men who have sex with other men disclose their serostatus to casual sex partners: results from a pilot study. AIDS Educ Prev. 2009;21:207–19.CrossRefPubMedCentralPubMed
15.
go back to reference Simoni JM, Pantalone DW. HIV disclosure and safer sex. In: Kalichman SC, editor. Positive prevention. New York: Kluwer; 2005. p. 65–98.CrossRef Simoni JM, Pantalone DW. HIV disclosure and safer sex. In: Kalichman SC, editor. Positive prevention. New York: Kluwer; 2005. p. 65–98.CrossRef
17.
go back to reference Galletly CL, Pinkerton SD. Toward rational criminal HIV exposure laws. J Law Med Ethics. 2004;32:327–37.CrossRefPubMed Galletly CL, Pinkerton SD. Toward rational criminal HIV exposure laws. J Law Med Ethics. 2004;32:327–37.CrossRefPubMed
18.
go back to reference Galletly CL, Pinkerton SD, DiFranceisco WD. A quantitative study of Michigan’s criminal HIV exposure law. AIDS Care. 2011;24:174–9.PubMedCentralPubMed Galletly CL, Pinkerton SD, DiFranceisco WD. A quantitative study of Michigan’s criminal HIV exposure law. AIDS Care. 2011;24:174–9.PubMedCentralPubMed
19.
go back to reference Galletly CL, Glasman LR, Pinkerton SD, DiFranceisco WD. New Jersey’s HIV exposure law and the HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV. Am J Public Health. 2012;102(11):2135–40.CrossRefPubMedCentralPubMed Galletly CL, Glasman LR, Pinkerton SD, DiFranceisco WD. New Jersey’s HIV exposure law and the HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV. Am J Public Health. 2012;102(11):2135–40.CrossRefPubMedCentralPubMed
21.
go back to reference Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS Behav. 2006;2006(10):451–61.CrossRef Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS Behav. 2006;2006(10):451–61.CrossRef
22.
go back to reference Kretzschmar M, Wiessing L. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users. AIDS. 2008;22:1527–37.CrossRefPubMed Kretzschmar M, Wiessing L. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users. AIDS. 2008;22:1527–37.CrossRefPubMed
24.
go back to reference Reed SJ. A study of the validity of a modified ordinal scale of HIV transmission risk among seropositive men who have sex with men (dissertation). Columbus, OH: The Ohio State University; 2012. Reed SJ. A study of the validity of a modified ordinal scale of HIV transmission risk among seropositive men who have sex with men (dissertation). Columbus, OH: The Ohio State University; 2012.
25.
go back to reference Pryzbyla SM, Golin CE, Widman L, Grodensky CA, Earp JA, Suchindran C. Serostatus disclosure to sexual partners among people living with HIV: examining the roles of partner characteristics and stigma. AIDS Care. 2013;25:566–72.CrossRef Pryzbyla SM, Golin CE, Widman L, Grodensky CA, Earp JA, Suchindran C. Serostatus disclosure to sexual partners among people living with HIV: examining the roles of partner characteristics and stigma. AIDS Care. 2013;25:566–72.CrossRef
26.
go back to reference Hoff CC, Chakravarty MA, Beougher SC, Neilands TB, Darbes LA. Relationship characteristics associated with sexual risk behavior among MSM in committed relationships. AIDS Patient Care STDs. 2012;26:738–45.CrossRefPubMedCentralPubMed Hoff CC, Chakravarty MA, Beougher SC, Neilands TB, Darbes LA. Relationship characteristics associated with sexual risk behavior among MSM in committed relationships. AIDS Patient Care STDs. 2012;26:738–45.CrossRefPubMedCentralPubMed
Metadata
Title
The Efficacy of Serostatus Disclosure for HIV Transmission Risk Reduction
Authors
Ann A. O’Connell
Sandra J. Reed
Julianne A. Serovich
Publication date
01-02-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0848-2

Other articles of this Issue 2/2015

AIDS and Behavior 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.